- 2023
-
Press releases - 27.03.2023
Towards a Better Understanding of the Role of Male Hormones in Women with Multiple Sclerosis
Multiple sclerosis (MS), an autoimmune disease for which there is no cure as yet, affects three women for every one man. Faced with this observation, scientists are studying the role of the sex hormones in order to better understand the differences between men and women in relation to the disease and its progression.
-
Press releases - 21.03.2023
COVID-19: Infection-Vaccination is the Most Protective Combination Against Reinfection
A large part of the population has developed immunity against SARS-CoV-2 following infection, vaccination – or both. In addition, some infected patients enjoy “hybrid” immunity when they are vaccinated following their infectious episode.
-
Press releases - 20.03.2023
Using Modeling to Limit Infectious Disease Transmission at Airports and Train Stations
In crowded places, such as airports and train stations, social distancing is difficult to maintain and the risk of infectious disease transmission is increased. In order to reduce this risk, it is essential that we improve our understanding of the dynamics of disease transmission within such places and the effective mitigation measures that can be implemented at low cost.
-
Press releases - 17.03.2023
Extreme Temperatures During Pregnancy: A Possible Impact on the Lung Development of Newborn Girls
Exposure to extreme temperatures from the fetal stage could impact health. This is what suggests a study by researchers from Inserm, Université Grenoble Alpes and CNRS, based on the SEPAGES cohort, intended to study the impact of various environmental factors on the health of pregnant women and their children.
-
Press releases - 10.03.2023
Against Whooping Cough and Its Transmission, a New Safe and Effective Nasal Vaccine
Highly infectious and potentially life-threatening in infants, whooping cough, caused by the bacterium Bordetella pertussis, continues to circulate to a large extent throughout the world. Although the vaccines currently used protect against the onset of symptoms, they have limited durability and cannot prevent bacterial infection resulting in transmission between individuals.
-
Press releases - 07.03.2023
A New Milestone in the Development of an Effective Allergic Asthma Vaccine
To combat allergic asthma, which affects millions of people worldwide, scientists from Inserm, CNRS and Université Toulouse III-Paul Sabatier at the Infinity laboratory[1], Institut Pasteur and French company NEOVACS are developing and testing a new vaccine.
-
Press releases - 27.02.2023
Pre- and Postnatal Chlordecone Exposure Could Affect the Cognitive Development and Behavior of Children
Despite the fact that chlordecone has not been used as an insecticide in the French West Indies for 30 years now, its persistence in the environment continues to contaminate the populations.
-
Press releases - 23.02.2023
Cannabis: Insomnia Twice as Common Among Students Who Use It Every Day
In a new study, researchers from Inserm, Université de Bordeaux and Bordeaux University Hospital focused on cannabis use by students – with the knowledge that its consumption among 18-25-year-olds in France is particularly high – and tried to measure its effects on sleep.
-
Press releases - 23.02.2023
New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Sexually Transmitted Bacterial Infections and proven efficacy of the MVA-BN Vaccine Against Mpox
Une étude menée par une équipe de recherche de l’AP-HP, Université Paris Cité, l’Inserm, Sorbonne Université en collaboration avec AIDES et Coalition PLUS démontre à la fois l’efficacité d’un vaccin contre le méningocoque B dans la réduction du risque d’infection par le gonocoque et celle de l’utilisation de l’antibiotique doxycycline comme traitement préventif contre les infections sexuellement transmissibles, lorsqu’il est pris dans les 72 h suivant un rapport sexuel.
-
Press releases - 21.02.2023
A blood factor involved in depression
Scientists from the Institut Pasteur, CNRS and Inserm have discovered that administration of the GDF11 protein, which is known to regenerate murine neural stem cells, improves cognitive abilities and reduces the depressive state in aged mice. They also demonstrated the mechanism of action of this protein in different mouse models. The scientists then investigated these results further in relation to depression, and showed that in humans, the levels of GDF11 are inversely related to depressive episodes.